Benedetti et al. [49] engineered a synthetic repressor named the SOX2 epigenetic silencer (SES), inducing cell death in both glioma cell lines and patient-derived cancer stem cells in vitro and in vivo. Here, SOX2 is linked to central nervous system cancer.